1.Endothelial progenitor cells and ischemic cerebrovascular disease
International Journal of Cerebrovascular Diseases 2009;17(12):936-939
Endothelial progenitor cells (EPCs) are a precursor cell of endothelium that has the ability of differentiation and proliferation. In given conditions, EPCs can be mobilized to the ischemic tissue to participate in repairing the injured blood vessels and angiogenesis, and EPCs are regarded as a marker of vascular reparative capacity. Studies in recent years have indicated that the changes of EPC number play an important role in the occurrence and prognosis of cerebral ischemia. As a potential therapeutic strategy, EPCs may be used in ischemic cerebrovascular disease. This article reviews the application progress of EPCs in ischemic cerebrovascular disease.
2.Variation of cell proliferous capability and antiapoptosis factors in colon carcinogenesis
Yangyang CUI ; Jianbo LU ; Jingye WANG ; Jian SHEN ; Yangyanbing XI ; Chunyan WANG
Cancer Research and Clinic 2013;(5):316-319
Objective To investigate the expression of Ki-67,Survivin,Livin in dysplasia,colon carcinogenesis and para-carcinoma tissues,and to discuss the variation of cell proliferous capability in colon carcinogenesis and antiapoptosis factors.Methods 219 specimens were composed of mild,moderate and severe atypical hyperplasia,well,moderately,poorly differentiated adenocarcinoma,para-carcinoma tissues of 36,34,18,35,27,35 and 34 cases.Detected the expression of Ki-67,Survivin and Livin with tissue microarray and immunohistochemical methods.All data were statistically analyzed by SPSS 17.0.Results In mild,moderate and severe atypical hyperplasia,well,moderately,poorly differentiated adenocarcinoma and para-carcinoma tissues the expression of Ki-67 were (21.56 ± 19.20)%,(37.44 ± 17.41)%,(36.17 ± 17.41)%,(55.29 ± 16.13)%,(44.89 ± 29.67)%,(45.11 ± 29.24)%,(43.94 ± 28.84)%,Survivin were 13.8 %,44.1%,77.8 %,85.7 %,85.1%,91.4 %,91.1%,and Livin were 2.7 %,38.2 %,55.6 %,100.0 %,77.8 %,80.8 %,79.4 %.The differences of Ki-67,Survivin and Livin expression in each group were statistically significant (F =6.796,X2 =81.754,X2 =95.200,all P < 0.05).Ki-67 was significantly correlated with expression of Livin (r =0.360,P < 0.05) and no correlated with expression of Survivin (r =0.044,P > 0.05).Conclusion Colonic epithelium from mild atypical hyperplasia to proliferation of well-differentiated adenocarcinoma cells formed a peak,and gradually down to poorly differentiated adenocarcinoma formed a platform.When the colon epithelial cells to become cancerous,the capability of cell proliferation will significantly enhance,apoptosis inhibition will reach the peak and the tumor cell will happen the changes of malignant biological behavior.Tumor microenvironment may promote the cell proliferation in para-carcinoma tissues and the development of colon cancer.Livin may inhibit apoptosis and promot the progression in synergistic mechanism importing with Survivin,which play a role in the development of colonic adenocarcinoma.
3.Guiding of serum procalcitonin-guided antibiotic in elderly early-onset stroke-associated pneumonia
Wei LONG ; Lijuan LI ; Yuan ZHONG ; Huifeng GUO ; Jingye YANG ; Yu ZHANG ; Gang LU
Chinese Journal of Geriatrics 2013;(5):513-515
Objective To evaluate the effects of serum procalcitonin (PCT)-guided antibiotic therapy in elderly patients with early-onset stroke-associated pneumonia (EOP).Methods Totally 179 eligible elderly patients with EOP were randomly devided into 2 groups:standard therapy group (standard group,n=88) and PCT-guided group (PCT group,n=91).Patients in standard group received antibiotics according to antibiotics guidelines in China by the treating physicians.Patients in PCT group were treated with antibiotics for 5 days,then the antibiotic treatment was based on serum PCT levels as follows:discouraged if PCT<0.25 μg/L and encouraged if PCT≥0.25 μg/L.Length of hospitalization,duration of antibiotics,costs of hospitalization and antibiotics,clinical efficacy,andmortality,National Institutes of Health Stroke Scale (NIHSS) score and Barthel index (BI) on the 28th day were observed.Results There were no significant differences in clinical efficacy,mortality,NIHSS score and BI between the two groups on the 28th day [(85.7% vs.86.3%),(8.8% vs.7.9%),10.1 (7.8,16.2) vs.9.8 (6.0,15.5),60.1(42.5,82.3) vs.57.9 (39.2,84.8),respectively,all P> 0.05].The length of hospitalization,antibiotic duration,costs of hospitalization and antibiotics were lower in PCT group than in standard group [19 (10,38) d vs.26(17,42) d,10 (7,14) dvs.15 (6,21) d,3350 (2052,6163) yuanvs.10355 (6877,15421) yuan,7532 (4810,12116) yuan vs.5358 (3089,8144) yuan,respectively,all P<0.05].Conclusions PCT guidance of antibiotic therapy is effective and safe for the treatment of early-onset stroke associated pneumonia in elderly patients.It can reduce the antibiotic duration and costs of hospitalization.
4. The value of space glucose control in ICU stress hyperglycemia management
Juan LU ; Pengcheng LIU ; Lijun LIU ; Jianjun ZHU ; Baochun ZHOU ; Yan ZHU ; Jingye ZHAN ; Qunying BAO ; Xiaoyan TIAN
Chinese Journal of Emergency Medicine 2019;28(11):1395-1399
Objective:
To investigate the effect of space glucose control (SGC) on the quality of blood glucose management in ICU patients with stress hyperglycemia.
Methods:
A prospective, cross-controlled, quasi-trial was conducted to observe patients with ICU-induced stress hyperglycemia between January 2018 and January 2019. Patients with conventional blood glucose management served as the control group, and SGC blood glucose management was used as the intervention group. The enrolled patients were interchanged between the two groups every 24 h, and the end point was 96 h. The differences in blood glucose management quality indicators between the two groups were compared, including the average blood glucose level, the highest and lowest blood glucose level, the average blood glucose monitoring interval, and the accumulated insulin dosage. SPSS 23.0 was used to analyze the data. The paired
5.Dynamic changes and significance of antithrombin and fibrinolytic function in advanced lung cancer patients during chemotherapy.
Mingshan WANG ; Lihong YANG ; Jingye PAN ; Xiaoxia WANG ; Hong LU ; Meiyan LU ; Shaoxian CHEN ; Yupeng XIE
Chinese Journal of Lung Cancer 2007;10(3):226-228
BACKGROUNDThe prethrombotic state can be observed in advanced lung cancer patients. The aim of this study is to determine the dynamic changes and significance of antithrombin and fibrinolytic function in advanced lung cancer patients during chemotherapy.
METHODSAntithrombin activity (AT:A), fibrinogen (FIB), D-dimer (D-D), plasminogen activity (PLG), tissue plasminogen activator antigen (t-PA:Ag) and plasminogen activator inhibitor-1 antigen (PAI-1:Ag) were measured in 33 advanced lung can-cer patients before and after chemotherapy, and 30 healthy people as controls.
RESULTSBefore chemotherapy, lung cancer patients had significantly lower AT:A (P < 0.01) and higher D-D, PLG:A, PAI-1:Ag and FIB (P < 0.01) than those of controls. There was no significant difference in t-PA:Ag between lung cancer patients and controls (P > 0.05). During the chemotherapy, AT:A, D-D and t-PA:Ag of lung can-cer patients remarkably decreased (P < 0.01), and PLG:A, PAI-1:Ag and FIB remarkably increased (P < 0.01) compared to those before chemotherapy.
CONCLUSIONSChemotherapy may enhance the prethrombotic state in advanced lung cancer patients. Dynamic observation of antithrombin and fibrinolytic function during chemotherapy might be useful for preventing pulmonary hemorrhage and pulmonary infarct and estimating prognosis of those patients.